1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

17 Jan 2023
Admin
News Article

Dcgi Approves Market Authorisation For Siis Covid Vaccine Covovax As Heterologous Booster Dose

The Subject Expert Committee Of The Cdsco On Wednesday Deliberated On The Issue And Had Recommended For Market Authorisation Of Covid Jab Covovax As A Heterologous Booster Dose For Adults Who Have Been Administered Two Doses Of Covishield Or Covaxin," An Official Source Said.The Drug Controller General Of India (Dcgi ) Has Approved Market Authorisation To Covid-19 Vaccine Covovax As A Heterologous Booster Dose For Adults Who Have Been Administered Two Doses Of Covishield Or Covaxin, Official Sources Said On Monday. The Dcgi'S Approval Came Following Recommendation By The Subject Expert Committee Of The Central Drugs Standard Control Organisation (Cdsco)Serum Institute Of India India Drug Controller General Of India Covishield Covaxin Cdsco Serum Institute Of India (Sii), Had Recently Written To The Dcgi For The Approval Of Covovax Heterologous Booster Dose For Those Aged 18 Years And Above In View Of Escalating Covid-19 Pandemic Situation In Some Countries, An Official Source Had Said. "The Subject Expert Committee Of The Cdsco On Wednesday Deliberated On The Issue And Had Recommended For Market Authorisation Of Covid Jab Covovax As A Heterologous Booster Dose For Adults Who Have Been Administered Two Doses Of Covishield Or Covaxin," An Official Source Said. The Dcgi Had Approved Covovax For Restricted Use In Emergency Situations In Adults On December 28, 2021, In The 12-17 Age Group On March 9, 2022, And In Children Aged 7- 11 Years On June 28 Last Year Subject To Certain Conditions. Covovax Is Manufactured Through Technology Transfer From Novavax. It Has Been Approved By The European Medicines Agency For Conditional Marketing Authorisation. It Was Granted Emergency-Use Listing By The World Health Organization (Who) On December 17, 2021. In August 2020, Us-Based Vaccine Maker Novavax Inc. Had Announced A Licence Agreement With The Sii For The Development And Commercialization Of Nvxcov2373, Its Covid-19 Vaccine Candidate In India And Low-And-Middle-Income Countries.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!